Join our Newsletter — 33% off our NHI Course

How should healthcare organisations secure patient result portals before putting them live?

Healthcare organisations should treat patient result portals as high-risk systems and require basic security controls before deployment. That means authentication, strong authorization, input validation, and testing for information disclosure before public release. If a portal accepts only an identifier or sample number, attackers can enumerate records and expose sensitive health and identity data at scale.

What “secure before live” should mean for a patient result portal

A patient result portal should not go live until it has been tested as a production-grade access boundary for sensitive health data, not just as a user interface. The minimum bar is that a real patient can sign in, see only their own results, and that no one can infer or enumerate other records through the portal, the API, or predictable identifiers.

The biggest mistake is treating the portal as safe because the front end looks simple. In practice, exposure usually comes from broken authentication, weak authorization, insecure session handling, missing input controls, or a backend endpoint that returns results for anyone who can guess a number or identifier.

Controls that need to be working before launch

Authentication should be strong enough to resist account takeover and account sharing, with a clear decision on who the portal is meant to serve and how they prove they are the right user. For patient access, that usually means a real identity proofing and login design rather than a lightweight shortcut, because the portal is delivering regulated health information, not generic account data.

Authorization must be checked on every request that returns results, attachments, or metadata. A portal can have good login security and still fail if the backend only checks whether the caller is “logged in” instead of verifying that the specific result belongs to that patient. That is where object-level access control matters most.

Input validation and safe query handling are also essential because result portals often accept identifiers, dates of birth, lab numbers, or other lookup values. If those fields are not constrained and verified, the application may leak records through enumeration, injection, or error messages. The safest design is to assume any user-controlled lookup field will be probed, automated, and replayed.

Why exposure often appears only after you test for it

Patient portals often fail in the seams between the user interface, the API, and the data store. That is why pre-live testing should include direct requests against the backend, not only scripted browser testing, and should confirm that one authenticated user cannot access another user’s record by changing a parameter or reusing a session.

Testing should also look for information disclosure in error responses, page source, download links, and caching behaviour. If a portal exposes result filenames, internal identifiers, or predictable URLs, those clues can make large-scale record discovery easier even when the visible page seems restricted. For access-control weakness patterns, the OWASP API Security Top 10 is a useful reference point because many portal failures are really backend authorization failures.

Because this is healthcare data, the implementation bar should also reflect privacy and security-by-design expectations. The portal should be reviewed as a release gate, not a post-launch hardening task, with sensitive-result pathways validated end to end before any public user reaches them. The controls discussed in the ISO/IEC 27002:2022 Information Security Controls and the EU General Data Protection Regulation (GDPR) are both relevant when the portal processes personal health data and needs security-by-design discipline.

Standards & Framework Alignment

This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.

OWASP API Security Top 10 addresses the attack surface, OWASP ASVS sets the technical controls, and ISO/IEC 27001:2022 and GDPR define the regulatory obligations.

Framework Control / Reference Relevance
OWASP API Security Top 10 API1 — Broken Object Level Authorization Patient result portals depend on per-record access checks for each result lookup.
Recommendation — Enforce per-object authorization on every result request and block cross-patient record access.
OWASP ASVS V8 — Authorization The portal must verify each user can access only their own results before go-live.
Recommendation — Verify object-level authorization for every sensitive portal action and data fetch.
ISO/IEC 27001:2022 A.8.24 — Use of cryptography Sensitive portal data often needs encryption in transit and protection of exposed results.
Recommendation — Protect patient-result data in transit and at rest with approved cryptographic controls.
GDPR Art.25 — Data protection by design and by default Patient portals processing health data need privacy and security built in before release.
Recommendation — Build privacy and access controls into the portal before exposing any patient data.

Practitioner Guidance

What to prioritise: Treat direct object access checks as the highest-risk control. If a patient can change an identifier, record number, or URL and see another person’s result, the portal is not ready regardless of how polished the login flow looks.

What to verify: Test the portal the way an attacker would, by changing identifiers, replaying sessions, and calling backend endpoints directly. Also verify that failures do not disclose internal IDs, stack traces, or record existence through different error messages.

Decision rule: If the portal can expose a result that links a patient identity to a clinical outcome, require release approval only after negative testing proves that unauthorized lookup, enumeration, and cross-account access are blocked.

Practitioner takeaway: A patient result portal is safe to launch only when access control is verified at the data object level, not just at the page level, because the harm comes from one small bypass turning into mass disclosure.